Ovarian cancer deaths ‘falling worldwide’

Deaths from ovarian cancer worldwide have fallen over the last decade, thanks in large part to a rise in oral contraceptive usage.

This is according to research led by the University of Milan, which said the decline in hormone replacement therapy to manage menopausal symptoms may also have played a role in this shift, as well as the emergence of better diagnosis and treatment options.

For EU nations, death rates decreased by ten percent between 2002 and 2012 from an age-standardised death rate of 5.76 per 100,000 women to 5.19 per 100,000, while in the US the decline was an even more pronounced 16 percent.

Professor Paolo Boffetta, associate director for population Sciences at the Tisch Cancer Institute of the Icahn School of Medicine at Mount Sinai in New York, said the results "show how past use of hormone treatments has an impact on the mortality from ovarian cancer at the population level".

However, it was also noted that the pattern of decreases was inconsistent in some areas of the world, such as in Latin American countries and in certain European regions.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.